Skip to content

Author

Abdul Haseeb Riaz

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 11617: Cardiovascular Outcomes in Patients with Fatty Change of Liver Treated with Combined GLP-1 RA and SGLT2 Inhibitor Therapy versus GLP-1 RA Alone: A Propensity Score Matched TriNetX Analysis

Background: Fatty change of the liver is strongly associated with cardiovascular risk due to insulin resistance, dyslipidemia, and systemic inflammation. GLP-1 receptor agonists (GLP-1 RAs) and SGLT2 inhibitors (SGLT2is) each provide independent cardiovascular benefits. This study assesses whether combination therap...

M. Azhar, Aneesa Altaf, Ehsanullah Alokozay et al. · 0 citations
Book Open access Oct 2026

When Not to Diagnose: Evaluating Evidence-Sufficiency Recognition in ECG Multimodal Language Models with ECGTrustBench

ECGTrustBench is introduced, which evaluates evidence-sufficiency recognition as answerable-versus-insufficient QA over 3,300 image-question pairs, with corruption criteria unanimously approved by three licensed clinicians.

Qi-Jia Huang, Jing-Xia Jiang, F. Syed et al. · 0 citations
Review Open access Sep 2026

Clinical Outcomes of Combined TAVR-PCI Versus SAVR-CABG in Patients with Aortic Stenosis and Coronary Artery Disease: A Systematic Review and Meta-Analysis

Background/Objectives: Coronary artery disease coexists with severe aortic stenosis in about half of patients. Surgical aortic valve replacement with coronary artery bypass grafting (SAVR+CABG) is guideline-recommended, but transcatheter aortic valve replacement with percutaneous coronary intervention (TAVR+PCI) is inc...

R. R. Rodriguez Mejia, Mathhar Aldaoud, I. Momodu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.